Mimi Kim

Mimi Kim, Sc.D., is a distinguished Professor in the Department of Epidemiology & Population Health at Albert Einstein College of Medicine and Montefiore Einstein Comprehensive Cancer Center. With an impressive h-index of 65 and over 15,467 citations across 272 publications, she has established herself as a leading researcher in her field. Her work bridges clinical medicine and population health, with significant contributions to understanding autoimmune disorders and their impact on vulnerable populations.

• Albert Einstein College of Medicine - Epidemiology & Population Health
• Montefiore Einstein Comprehensive Cancer Center
• National Institute of Arthritis and Musculoskeletal and Skin Diseases
• National Center for Advancing Translational Sciences

Dr. Kim's research primarily focuses on systemic lupus erythematosus, particularly examining adverse pregnancy outcomes in women with autoimmune conditions. Her work extends to postmenopausal health, breast cancer epidemiology, and the statistical analysis of medical outcomes using hazard ratios and confidence intervals. She employs sophisticated epidemiological methods to address critical questions in women's health and chronic disease management.

Analysis of her recent publications reveals a strong interdisciplinary approach, spanning rheumatology, neuroimaging, and oncology. Her work on the IMPACT trial demonstrates leadership in clinical research for antiphospholipid syndrome, while her neuroimaging studies explore age-related brain changes. This breadth indicates a researcher who successfully bridges traditional disciplinary boundaries to address complex health questions.

Dr. Kim has secured significant research funding as both Principal Investigator and Co-Principal Investigator on multiple NIH grants, including the Einstein-Montefiore Clinical and Translational Science Award Hub and research focused on adverse pregnancy outcomes in women with systemic lupus erythematosus. Her grant portfolio demonstrates sustained support from major funding agencies for her innovative research programs spanning over a decade.

Her laboratory and research team operate at the intersection of clinical medicine and population health, collaborating with rheumatologists, obstetricians, neurologists, and oncologists. The Montefiore Einstein Comprehensive Cancer Center affiliation suggests active participation in multidisciplinary cancer research efforts, particularly regarding epidemiological aspects of cancer in specific patient populations.